Medicine for treating novel coronavirus and preparation method thereof

Abstract

The invention discloses a medicine for treating novel coronavirus, and compared with the prior art, the medicine comprises the following components in parts by weight: 0.5-25 parts of ginseng, 1-20 parts of astragalus membranaceus, 1-18 parts of gastrodia elata, 1-24 parts of earthworm, 1-26 parts of ligusticum wallichii, 0.1-15 parts of salvia miltiorrhiza, 0.1-10 parts of borneol, 1-28 parts of pseudo-ginseng, 1-32 parts of pinellia ternate, 0.1-14 parts of centipede and 0.1-17 parts of leech. According to the medicine for treating the novel coronavirus, through reasonable compatibility of the medicinal materials, the medicine for treating the novel coronavirus has the effect of rapidly improving the immunity in a short time, the active medicine components can activate immune cells to enhance the immune function of a human body, and the effect of treating the novel coronavirus is achieved. The traditional Chinese medicine composition is beneficial for treating patients infected with early novel coronavirus pneumonia.

Description

technical field [0001] The present application relates to the field of medicines for the treatment of novel coronaviruses, more specifically, to a medicine for the treatment of novel coronaviruses and a preparation method thereof. Background technique [0002] Coronavirus is a large family of viruses known to cause colds and more serious diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The virus strain is mainly manifested by fever, fatigue, and dry cough. Upper respiratory tract symptoms such as nasal congestion and runny nose are rare. About half of the patients have difficulty breathing after a week, and severe cases rapidly progress to acute respiratory distress syndrome, septic shock, Difficult to correct metabolic acidosis and coagulation dysfunction, some patients have mild onset symptoms, but no fever, and usually recover after 1 week. [0003] The elderly are susceptible to new coronary pneumonia, mainly because...

AI Technical Summary

Problems solved by technology

[0003] The elderly are susceptible to new coronary pneumonia, mainly because the elderly have weaker body immunity and poor respiratory function. The new crown pneumonia virus will replicate in the respiratory tract. When some patients have poor immunity, there is no way to rule out the new crown pneumonia virus. In this way It will cause aggravation of respiratory inflammation, and it will also turn into severe disease. In addition, if some elderly people have some basic diseases, such as high blood pressure and diabetes, it will also reduce the body's immunity. If they are infected with new coronary pneumonia, they will To become a critically ill patient, there is sufficient evidence to show that the full vaccination of the new coronavirus vaccine can effectively reduce the risk of severe illness or even death after the new coronavirus infection, but some elderly people do not meet the vaccination requirements of the new coronavirus vaccine, and those who are infected with the new coronavirus pneumonia greatly increased odds

Images